Health and Welfare Committee urged to expand bio-equivalent tests.

Published: 2001-06-28 06:56:00

Updated: 2001-06-28 06:56:00

The Health and Welfare Committee of the National Assembly discussed current issues in the KFDA's report meeting on June 22 especially over the bio-equivalent tests, the drug safety measure, the food safety and control system and the earlier health registration of orphan drugs like Gleevec capsule...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK